Trial
NCT01480232
A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
A. Eden Evins
Collaborators
FORUM Pharmaceuticals Inc; National Institute on Drug Abuse (NIDA)
Condition
Nicotine Dependence
Intervention
EVP-6124
Why stopped
Study has been put on clinical hold by FDA
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-06